Literature DB >> 21775206

Notch in T-ALL: new players in a complex disease.

Ute Koch1, Freddy Radtke.   

Abstract

T cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematopoietic malignancy of thymocytes affecting preferentially children and adolescents. The disease is heterogeneous and characterized by a large set of chromosomal and genetic alterations that deregulate the growth of maturing thymocytes. The identification of activating point mutations in NOTCH1 in more then 50% of all T-ALL cases highlights the NOTCH1 cascade as a central player of T-ALL pathogenesis. In this review, we summarize and update more recent findings on the molecular mechanisms of T-ALL with a particular emphasis on the oncogenic properties of aberrant NOTCH1 signaling.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21775206     DOI: 10.1016/j.it.2011.06.005

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  35 in total

1.  NOTCH1 mutations in CLL associated with trisomy 12.

Authors:  Veronica Balatti; Arianna Bottoni; Alexey Palamarchuk; Hansjuerg Alder; Laura Z Rassenti; Thomas J Kipps; Yuri Pekarsky; Carlo M Croce
Journal:  Blood       Date:  2011-11-15       Impact factor: 22.113

2.  An activating intragenic deletion in NOTCH1 in human T-ALL.

Authors:  J Erika Haydu; Kim De Keersmaecker; Mary Kaye Duff; Elisabeth Paietta; Janis Racevskis; Peter H Wiernik; Jacob M Rowe; Adolfo Ferrando
Journal:  Blood       Date:  2012-04-17       Impact factor: 22.113

Review 3.  Notch and disease: a growing field.

Authors:  Angeliki Louvi; Spyros Artavanis-Tsakonas
Journal:  Semin Cell Dev Biol       Date:  2012-02-20       Impact factor: 7.727

4.  Gamma secretase inhibitors enhance vincristine-induced apoptosis in T-ALL in a NOTCH-independent manner.

Authors:  Sun-Ok Yoon; Mariana C Zapata; Akannsha Singh; Wol Soon Jo; Nakia Spencer; Yong Sung Choi
Journal:  Apoptosis       Date:  2014-11       Impact factor: 4.677

5.  Small molecules intercept Notch signaling and the early secretory pathway.

Authors:  Andreas Krämer; Torben Mentrup; Bertrand Kleizen; Eric Rivera-Milla; Daniela Reichenbach; Christoph Enzensperger; Richard Nohl; Eric Täuscher; Helmar Görls; Aspasia Ploubidou; Christoph Englert; Oliver Werz; Hans-Dieter Arndt; Christoph Kaether
Journal:  Nat Chem Biol       Date:  2013-09-29       Impact factor: 15.040

Review 6.  Notch as a tumour suppressor.

Authors:  Craig S Nowell; Freddy Radtke
Journal:  Nat Rev Cancer       Date:  2017-02-03       Impact factor: 60.716

Review 7.  Zebrafish Models of Human Leukemia: Technological Advances and Mechanistic Insights.

Authors:  Nicholas R Harrison; Fabrice J F Laroche; Alejandro Gutierrez; Hui Feng
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

8.  Phenothiazines induce PP2A-mediated apoptosis in T cell acute lymphoblastic leukemia.

Authors:  Alejandro Gutierrez; Li Pan; Richard W J Groen; Frederic Baleydier; Alex Kentsis; Jason Marineau; Ruta Grebliunaite; Elena Kozakewich; Casie Reed; Francoise Pflumio; Sandrine Poglio; Benjamin Uzan; Paul Clemons; Lynn VerPlank; Frank An; Jason Burbank; Stephanie Norton; Nicola Tolliday; Hanno Steen; Andrew P Weng; Huipin Yuan; James E Bradner; Constantine Mitsiades; A Thomas Look; Jon C Aster
Journal:  J Clin Invest       Date:  2014-01-09       Impact factor: 14.808

9.  The TCR γδ repertoire and relative gene expression characteristics of T-ALL cases with biclonal malignant Vδ1 and Vδ2 T cells.

Authors:  Haitao Zheng; Xu Wang; Yu Ma; Bing Xu; Shaohua Chen; Lijian Yang; Xiuli Wu; Grzegorz K Przybylski; Suming Huang; Tiezhen Ye; Yangqiu Li
Journal:  DNA Cell Biol       Date:  2013-12-13       Impact factor: 3.311

10.  Trisomy 12 CLLs progress through NOTCH1 mutations.

Authors:  V Balatti; S Lerner; L Rizzotto; L Z Rassenti; A Bottoni; A Palamarchuk; L Cascione; H Alder; M J Keating; T J Kipps; Y Pekarsky; C M Croce
Journal:  Leukemia       Date:  2012-08-20       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.